Nippon India Pharma Fund Overview
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 21-02-2025
NAV ₹464.52(R) -1.39% ₹515.49(D) -1.39%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 6.77% 18.73% 22.97% 18.98% 13.7%
Direct 7.73% 19.8% 24.09% 20.04% 14.72%
Nifty Pharma TRI 8.49% 16.98% 20.4% 13.51% 6.47%
SIP (XIRR) Regular -2.16% 21.18% 19.2% 20.29% 17.15%
Direct -1.25% 22.3% 20.29% 21.38% 18.15%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.7 0.37 0.9 2.34% 0.12
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.34% -16.24% -10.33% 0.9 10.59%
Top Pharma Fund
Fund Name Rank Rating
Sbi Healthcare Opportunities Fund -
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Tata India Pharma & Healthcare Fund -
Dsp Healthcare Fund -
Uti Healthcare Fund -
Nippon India Pharma Fund -
Mirae Asset Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -

NAV Date: 21-02-2025

Scheme Name NAV Rupee Change Percent Change
NIPPON INDIA PHARMA FUND - IDCW Option 108.27
-11.6700
-9.7300%
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option 152.22
-15.3300
-9.1500%
Nippon India Pharma Fund-Growth Plan-Growth Option 464.52
-6.5500
-1.3900%
Nippon India Pharma Fund-Growth Plan-Bonus Option 464.52
-6.5500
-1.3900%
Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option 515.49
-7.2600
-1.3900%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 515.49
-7.2600
-1.3900%

Review Date: 21-02-2025

A review of the different performance parameters of the fund is as follows:
  1. Returns: It denotes the rise in the investment's worth during the investment period, expressed as a percentage or a monetary value. As part of our analysis, we evaluated six return parameters of this fund. We have classified the return parameters into three performance groups: the top 25%, parameters that fall below the top 25% but remain above average, and parameters that are below average. The performance of each parameter is outlined below.
    1. Top 25%: One return parameter of the Nippon India Pharma Fund is in the top 25% in the category, as shown below:
      • 1M Return %
    2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
    3. Below Average: Five return parameters of the fund are below average in the category, which are listed below:
      • 5Y Return %
      • 3Y Return %
      • 1Y Return %
      • 3M Return %
      • 6M Return %
  2. Risk: It refers to the chance of suffering a financial loss or not reaching the expected profits due to a variety of circumstances. Two risk parameters of the fund are divided into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Nippon India Pharma Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Nippon India Pharma Fund has two risk parameters that are below average but above the lowest 25% in the category. These are:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 15.34 %.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.59 %.
    3. Above Average: Nippon India Pharma Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: Risk-adjusted performance parameters in mutual funds are parameters that assess the return on investments based on the risks involved. These parameters provide a platform for investors to compare various investments, by considering both profits and the risks involved. For Nippon India Pharma Fund, we have evaluated four risk-adjusted performance parameters.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: Nippon India Pharma Fund has four risk-adjusted performance parameters of the fund that are below average in the category.
      • Sharpe Ratio: Nippon India Pharma Fund has a Sharpe Ratio of 0.7 compared to the category average of 0.79.
      • Sterling Ratio: Nippon India Pharma Fund has a Sterling Ratio of 0.9 compared to the category average of 0.93.
      • Sortino Ratio: Nippon India Pharma Fund has a Sortino Ratio of 0.37 compared to the category average of 0.43.
      • Treynor Ratio: Nippon India Pharma Fund has a Treynor Ratio of 0.12 compared to the category average of 0.14.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -6.00 -6.64
-6.97
-9.04 | -5.72 3 | 13 Very Good
3M Return % -7.26 -6.02
-6.79
-9.68 | -4.84 9 | 13 Average
6M Return % -8.47 -9.49
-6.24
-17.69 | -0.25 10 | 13 Average
1Y Return % 6.77 8.49
11.55
1.74 | 21.28 10 | 13 Average
3Y Return % 18.73 16.98
19.78
17.06 | 22.67 6 | 8 Average
5Y Return % 22.97 20.40
23.20
19.41 | 25.85 6 | 8 Average
7Y Return % 18.98 13.51
18.01
16.89 | 18.98 1 | 4 Very Good
10Y Return % 13.70 6.47
12.44
11.19 | 13.70 1 | 3 Very Good
15Y Return % 17.19 13.03
16.72
15.30 | 17.67 2 | 3 Good
1Y SIP Return % -2.16
1.08
-11.88 | 13.28 9 | 13 Average
3Y SIP Return % 21.18
23.30
20.70 | 27.21 6 | 8 Average
5Y SIP Return % 19.20
20.31
17.57 | 22.93 6 | 8 Average
7Y SIP Return % 20.29
20.75
20.17 | 22.22 3 | 4 Average
10Y SIP Return % 17.15
16.62
15.92 | 17.15 1 | 3 Very Good
15Y SIP Return % 16.91
16.23
14.98 | 16.91 1 | 3 Very Good
Standard Deviation 15.34
15.52
14.01 | 16.25 3 | 8 Good
Semi Deviation 10.59
10.65
10.12 | 11.03 4 | 8 Good
Max Drawdown % -10.33
-11.33
-13.44 | -9.85 3 | 8 Good
VaR 1 Y % -16.24
-18.16
-22.20 | -15.67 2 | 8 Very Good
Average Drawdown % -5.65
-5.01
-6.33 | -4.14 6 | 8 Average
Sharpe Ratio 0.70
0.79
0.59 | 1.08 6 | 8 Average
Sterling Ratio 0.90
0.93
0.76 | 1.16 4 | 8 Good
Sortino Ratio 0.37
0.43
0.32 | 0.56 6 | 8 Average
Jensen Alpha % 2.34
3.87
0.23 | 8.88 6 | 8 Average
Treynor Ratio 0.12
0.14
0.10 | 0.19 6 | 8 Average
Modigliani Square Measure % 19.78
21.33
17.54 | 27.27 6 | 8 Average
Alpha % 0.56
2.09
-0.60 | 5.31 6 | 8 Average
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -5.93 -6.64 -6.87 -8.93 | -5.64 3 | 13
3M Return % -7.05 -6.02 -6.48 -9.30 | -4.55 9 | 13
6M Return % -8.05 -9.49 -5.62 -16.99 | 0.61 11 | 13
1Y Return % 7.73 8.49 13.01 3.43 | 22.79 11 | 13
3Y Return % 19.80 16.98 21.22 18.82 | 23.98 6 | 8
5Y Return % 24.09 20.40 24.74 21.24 | 27.02 6 | 8
7Y Return % 20.04 13.51 19.36 18.09 | 20.04 1 | 4
10Y Return % 14.72 6.47 13.57 12.30 | 14.72 1 | 3
1Y SIP Return % -1.25 2.46 -10.32 | 14.73 9 | 13
3Y SIP Return % 22.30 24.80 22.30 | 28.34 8 | 8
5Y SIP Return % 20.29 21.78 19.27 | 24.02 7 | 8
7Y SIP Return % 21.38 22.11 21.38 | 23.53 4 | 4
10Y SIP Return % 18.15 17.72 17.02 | 18.15 1 | 3
Standard Deviation 15.34 15.52 14.01 | 16.25 3 | 8
Semi Deviation 10.59 10.65 10.12 | 11.03 4 | 8
Max Drawdown % -10.33 -11.33 -13.44 | -9.85 3 | 8
VaR 1 Y % -16.24 -18.16 -22.20 | -15.67 2 | 8
Average Drawdown % -5.65 -5.01 -6.33 | -4.14 6 | 8
Sharpe Ratio 0.70 0.79 0.59 | 1.08 6 | 8
Sterling Ratio 0.90 0.93 0.76 | 1.16 4 | 8
Sortino Ratio 0.37 0.43 0.32 | 0.56 6 | 8
Jensen Alpha % 2.34 3.87 0.23 | 8.88 6 | 8
Treynor Ratio 0.12 0.14 0.10 | 0.19 6 | 8
Modigliani Square Measure % 19.78 21.33 17.54 | 27.27 6 | 8
Alpha % 0.56 2.09 -0.60 | 5.31 6 | 8
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D -1.39 ₹ 9,861.00 -1.39 ₹ 9,861.00
1W -0.02 ₹ 9,998.00 0.00 ₹ 10,000.00
1M -6.00 ₹ 9,400.00 -5.93 ₹ 9,407.00
3M -7.26 ₹ 9,274.00 -7.05 ₹ 9,295.00
6M -8.47 ₹ 9,153.00 -8.05 ₹ 9,195.00
1Y 6.77 ₹ 10,677.00 7.73 ₹ 10,773.00
3Y 18.73 ₹ 16,738.00 19.80 ₹ 17,195.00
5Y 22.97 ₹ 28,121.00 24.09 ₹ 29,428.00
7Y 18.98 ₹ 33,745.00 20.04 ₹ 35,907.00
10Y 13.70 ₹ 36,119.00 14.72 ₹ 39,469.00
15Y 17.19 ₹ 108,030.00 ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 -2.16 ₹ 11,858.16 -1.25 ₹ 11,918.42
3Y ₹ 36000 21.19 ₹ 49,128.88 22.30 ₹ 49,894.56
5Y ₹ 60000 19.20 ₹ 96,891.12 20.29 ₹ 99,499.32
7Y ₹ 84000 20.29 ₹ 173,265.54 21.38 ₹ 180,113.56
10Y ₹ 120000 17.15 ₹ 295,532.76 18.15 ₹ 312,039.60
15Y ₹ 180000 16.91 ₹ 729,231.30 ₹


Date Nippon India Pharma Fund NAV Regular Growth Nippon India Pharma Fund NAV Direct Growth
21-02-2025 464.5158 515.4939
20-02-2025 471.0695 522.7538
19-02-2025 470.5405 522.1537
18-02-2025 470.7847 522.4116
17-02-2025 470.4532 522.0308
14-02-2025 464.6151 515.5136
13-02-2025 475.034 527.0608
12-02-2025 473.0778 524.8773
11-02-2025 475.7042 527.7784
10-02-2025 487.1205 540.4312
07-02-2025 497.0274 551.382
06-02-2025 497.6849 552.0979
05-02-2025 493.2762 547.1939
04-02-2025 486.9167 540.1261
03-02-2025 482.2056 534.8871
31-01-2025 480.3605 532.8014
30-01-2025 479.1891 531.4891
29-01-2025 474.3303 526.0872
28-01-2025 465.7902 516.6027
27-01-2025 475.1362 526.9554
24-01-2025 486.7427 539.7882
23-01-2025 498.0877 552.356
22-01-2025 493.8616 547.6562
21-01-2025 494.19 548.0069

Fund Launch Date: 10/May/2004
Fund Category: Pharma Fund
Investment Objective: The Fund seeks to invest in pharma sector with focus on important segments of the sector viz Domestic Business, International & CRAMS and include deep value as well as high growth pharma businesses. The fund invests across market capitalization within the sector. It may suit investment horizon of around 2-3 years
Fund Description: An open ended equity scheme investing in pharma sector
Fund Benchmark: S&P BSE Healthcare TR
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.